GSA CAPITAL PARTNERS LLP - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 191 filers reported holding HERON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$97
-66.7%
64,528
-44.6%
0.01%
-72.2%
Q4 2022$291
-99.9%
116,574
+34.8%
0.04%
-25.0%
Q3 2022$365,000
-35.1%
86,459
-57.1%
0.05%
-42.9%
Q2 2022$562,000
-33.7%
201,424
+35.8%
0.08%
-26.3%
Q1 2022$848,000
+170.1%
148,272
+331.3%
0.11%
+192.3%
Q4 2021$314,000
-19.5%
34,374
-5.7%
0.04%
-2.5%
Q3 2021$390,000
-58.2%
36,442
-39.4%
0.04%
-61.9%
Q2 2021$933,000
+72.5%
60,093
+80.1%
0.10%
+16.7%
Q1 2021$541,000
-13.4%
33,369
-20.9%
0.09%
-13.5%
Q3 2020$625,000
+31.6%
42,177
+4.2%
0.10%
-12.6%
Q1 2020$475,000
-26.7%
40,459
+46.8%
0.12%
+58.7%
Q4 2019$648,00027,5590.08%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
TANG KEVIN C 21,288$250,00019.87%
TANG CAPITAL MANAGEMENT LLC 2,896,904$34,010,0004.78%
PFM Health Sciences, LP 2,481,917$29,138,0002.39%
Iron Triangle Partners LP 500,000$5,870,0002.27%
NEXPOINT ASSET MANAGEMENT, L.P. 777,599$9,129,0001.72%
Pekin Hardy Strauss, Inc. 588,732$6,912,0001.55%
First Light Asset Management, LLC 691,400$8,117,0001.39%
Congress Park Capital LLC 111,045$1,304,0001.18%
Mesirow Financial Investment Management, Inc. 15,135$178,0001.12%
Elk Creek Partners, LLC 509,174$5,978,0001.03%
View complete list of HERON THERAPEUTICS INC shareholders